Ae Wealth Management LLC Exelixis, Inc. Transaction History

Ae Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $1,155 - $1,447	60 Added 0.59%	10,245 $245,000
Q3 2023 Oct 11, 2023	SELL	$19.04 - $22.74 $11,290 - $13,484	-593 Reduced 5.5%	10,185 $222,000
Q2 2023 Jul 10, 2023	SELL	$18.17 - $20.48 $41,954 - $47,288	-2,309 Reduced 17.64%	10,778 $205,000
Q1 2023 Apr 14, 2023	SELL	$16.3 - $19.41 $374 - $446	-23 Reduced 0.18%	13,087 $254,000
Q4 2022 Jan 31, 2023	BUY	$14.96 - $17.39 $196,125 - $227,982	13,110 New	13,110 $210,000
Q3 2020 Nov 06, 2020	SELL	$20.67 - $26.94 $589,095 - $767,790	-28,500 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$16.46 - $27.42 $469,110 - $781,470	28,500 New	28,500 $677,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.